Search Login Register

anagrelide (Agrylin) Summary

Description: imidazoquinazoline derivative which lowers platelet count probably by inhibiting thrombopoiesis and reduces platelet aggregation; used for thrombocythemia; structure in first source

Also Known As: Agrylin; anagrelide hydrochloride; 6,7-dichloro-1,5-dihydroimidazo(2,1-b)quinazolin-2(3H)-one hydrochloride; Agrelin; BL 4162A Show All >>

Networked: 149 relevant articles (18 outcomes, 31 trials/studies) for this Drug

Key Diseases for which anagrelide is Relevant

  1. Essential Thrombocythemia : 6 outcomes 13 studies in 67 results
  2. Thrombocytosis (Thrombocythemia) : 6 outcomes 8 studies in 50 results
  3. Myeloproliferative Disorders (Myeloproliferative Disorder) : 3 outcomes 6 studies in 30 results
  4. Leukemia : 2 outcomes 2 studies in 5 results
  5. Hemorrhage : 1 outcome 5 studies in 10 results
Show All >>

Drugs Related to anagrelide

  1. Hydroxyurea (Hydrea)
  2. Aspirin (Acetylsalicylic Acid)
  3. Interferon-alpha (Interferon Alfa)
  4. Reticulin (Reticular Fiber)
  5. imatinib (Gleevec)
  6. Troponin I
  7. Cytarabine (Cytosar-U)
  8. pro-brain natriuretic peptide (1-76)
  9. anagrelide (Agrylin)
  10. Interferons
Show All >>

Therapies Related to anagrelide

  1. Bone Marrow Transplantation (Transplantation, Bone Marrow)
  2. Splenectomy
  3. Stem Cell Transplantation
  4. Renal Dialysis (Hemodialysis)
  5. Drug Therapy (Chemotherapy)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.